Learning Objectives
5 objectives- Understand the unique physiological and pharmacological considerations in administering anaesthesia to special populations including paediatric, geriatric, obstetric, and patients with systemic diseases.
- Develop competency in selecting appropriate anaesthetic techniques and agents tailored to patients with cardiovascular, respiratory, renal, hepatic, neurological, and obesity-related challenges.
- Apply strategies for preoperative assessment, intraoperative management, and postoperative care to optimize safety and outcomes in high-risk patient groups.
- Analyze and manage potential complications arising from anaesthesia in diverse clinical scenarios involving systemic comorbidities.
- Integrate evidence-based practices for monitoring and managing airway, hemodynamic, and metabolic parameters specific to special populations.
Content Outline
PreviewUnit 1488: Advanced Clinical Anaesthesia in Special Populations
1. Introduction to Anaesthesia in Special Populations
- Overview of challenges and importance of tailored anaesthetic management
- Principles of pharmacokinetics and pharmacodynamics variations
2. Paediatric Anaesthesia
2.1 Unique Physiological Considerations
- Differences in airway anatomy and respiratory physiology
- Cardiovascular and metabolic variations
2.2 Anaesthetic Drug Dosages and Pharmacology
- Weight-based dosing principles
- Age-related drug metabolism and clearance
2.3 Airway Management Techniques
- Use of pediatric airway devices
- Difficult airway considerations
2.4 Monitoring in Paediatric Patients
- Vital signs and capnography
- Temperature regulation
3. Geriatric Anaesthesia
3.1 Physiological Changes Affecting Anaesthesia
- Decreased organ functional reserve (cardiac, renal, hepatic)
- Altered drug metabolism and sensitivity
3.2 Comorbidities and Polypharmacy
- Assessment of cardiovascular, respiratory, and neurological status
- Drug interactions and cautious dosing
3.3 Strategies for Safe Management
- Preoperative optimization
- Intraoperative monitoring and fluid management
- Postoperative delirium and cognitive dysfunction prevention
4. Obstetric Anaesthesia
4.1 Physiological Changes in Pregnancy
- Cardiovascular, respiratory, and gastrointestinal adaptations
4.2 Effects of Anaesthetic Drugs on Mother and Fetus
- Placental transfer and fetal considerations
- Teratogenicity and neonatal depression
4.3 Pain Management During Labour
- Regional techniques (epidural, spinal)
- Systemic analgesia options
4.4 Anaesthesia for Caesarean Section
- Choice of anaesthetic technique
- Maternal and fetal monitoring
5. Anaesthesia in Patients with Cardiovascular Disease
5.1 Common Cardiovascular Conditions
- Ischemic heart disease, heart failure, arrhythmias, valvular disorders
5.2 Anaesthetic Agent Selection
- Hemodynamic effects of agents
- Avoidance of myocardial depressants
5.3 Monitoring and Hemodynamic Stability
- Invasive vs non-invasive monitoring
- Management of blood pressure and heart rate
5.4 Optimization Strategies
- Preoperative cardiac assessment
- Perioperative beta-blocker and anticoagulant management
6. Anaesthesia in Patients with Respiratory Disease
6.1 Respiratory Conditions Overview
- Asthma, COPD, obstructive sleep apnea
6.2 Preoperative Assessment
- Pulmonary function tests
- Optimization of respiratory status
6.3 Airway Management Challenges
- Risk of bronchospasm and airway obstruction
- Ventilation strategies
6.4 Postoperative Respiratory Care
- Monitoring for hypoventilation and oxygenation
- Physiotherapy and early mobilization
7. Anaesthesia in Patients with Renal Dysfunction
7.1 Impact on Drug Metabolism and Excretion
- Altered pharmacokinetics of renally-excreted drugs
7.2 Fluid and Electrolyte Management
- Avoidance of fluid overload
- Correction of electrolyte imbalances
7.3 Drug Dosing Adjustments
- Selection of anaesthetic agents with minimal renal toxicity
7.4 Avoidance of Nephrotoxic Agents
- NSAIDs and contrast media considerations
8. Anaesthesia in Patients with Hepatic Dysfunction
8.1 Effects on Drug Metabolism
- Impaired hepatic clearance and altered protein binding
8.2 Coagulation and Hemodynamic Considerations
- Risk of bleeding due to coagulopathy
- Portal hypertension and fluid shifts
8.3 Perioperative Management Strategies
- Choice of anesthetics with minimal hepatic metabolism
- Monitoring and correcting coagulation abnormalities
9. Anaesthesia in Patients with Neurological Disorders
9.1 Common Neurological Conditions
- Epilepsy, Parkinson's disease, stroke
9.2 Drug Interactions and Seizure Management
- Avoidance of proconvulsant agents
- Maintenance of anticonvulsant therapy
9.3 Neuroprotective Strategies
- Optimal cerebral perfusion and oxygenation
- Avoidance of increased intracranial pressure
10. Anaesthesia in Patients with Obesity
10.1 Physiological Implications
- Airway anatomy changes and ventilation challenges
- Cardiovascular and metabolic alterations
10.2 Airway Management
- Difficult airway prediction and planning
- Use of specialized equipment
10.3 Ventilation and Oxygenation
- Strategies to prevent hypoventilation and atelectasis
10.4 Perioperative Care Strategies
- Thromboprophylaxis
- Dosing adjustments for lipophilic and hydrophilic drugs
11. Summary and Integration
- Case studies and clinical scenario discussions
- Best practice guidelines and evidence-based recommendations
Unlock the full outline
Get the complete content outline, learning outcomes and assessment methods for Anaesthesia In Special Populations.
KSh 20 one-off, or included with a plan
Learning Outcomes
Unlock the outline above to see learning outcomes.
Assessment Methods
Unlock the outline above to see assessment methods.